These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 24206050

  • 1. False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review.
    Taguchi K, Ohmura T, Ohya Y, Horio M, Furukawa K, Jono H, Inomata Y, Saito H.
    Exp Clin Transplant; 2014 Oct; 12(5):474-8. PubMed ID: 24206050
    [Abstract] [Full Text] [Related]

  • 2. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T, Takeuchi H, Nakamura Y, Konno O, Yokoyama T, Iwamoto H, Hama K, Hirano T, Unezaki S, Okuyama K, Shimazu M.
    Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J, Tutor JC.
    Ther Drug Monit; 2009 Apr; 31(2):269-72. PubMed ID: 19258927
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 6. Falsely elevated tacrolimus concentrations measured using the ACMIA method due to circulating endogenous antibodies in a kidney transplant recipient.
    D'Alessandro M, Mariani P, Mennini G, Severi D, Berloco P, Bachetoni A.
    Clin Chim Acta; 2011 Jan 30; 412(3-4):245-8. PubMed ID: 21059349
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L.
    Transplant Proc; 2006 Jan 30; 38(1):94-6. PubMed ID: 16504673
    [Abstract] [Full Text] [Related]

  • 9. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M.
    Clin Biochem; 2005 Jun 30; 38(6):552-7. PubMed ID: 15885236
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of the plasma concentration of tacrolimus: a useful method for distinguishing falsely elevated tacrolimus concentrations reported by the ACMIA.
    Yamaoka M, Kawamura R, Shioda Y, Ogawa N, Koyama I, Saitoh T, Ikebuchi K.
    Rinsho Byori; 2010 Dec 30; 58(12):1188-92. PubMed ID: 21344794
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct 30; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 15. Falsely elevated tacrolimus levels caused by immunoassay interference secondary to beta-galactosidase antibodies in an infected liver transplant recipient.
    Knorr JP, Grewal KS, Balasubramanian M, Young N, Zaki R, Khanmoradi K, Araya V, Ortiz J.
    Pharmacotherapy; 2010 Sep 30; 30(9):954. PubMed ID: 20812435
    [Abstract] [Full Text] [Related]

  • 16. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
    Hashi S, Masuda S, Kikuchi M, Uesugi M, Yano I, Omura T, Yonezawa A, Fujimoto Y, Ogawa K, Kaido T, Uemoto S, Matsubara K.
    Transplant Proc; 2014 Apr 30; 46(3):758-60. PubMed ID: 24767342
    [Abstract] [Full Text] [Related]

  • 17. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F, Debord J, Parant F, Labalette M, Kamar N, Rostaing L, Rousseau A, Marquet P.
    Ther Drug Monit; 2011 Apr 30; 33(2):171-7. PubMed ID: 21383655
    [Abstract] [Full Text] [Related]

  • 18. Apparent elevation of cyclosporine whole blood concentrations in a renal allograft recipient.
    de Jonge H, Geerts I, Declercq P, de Loor H, Claes K, Desmet K, Kuypers DR.
    Ther Drug Monit; 2010 Oct 30; 32(5):529-31. PubMed ID: 20625351
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
    Moscato D, Nonnato A, Adamo R, Vancheri M, Caropreso A.
    Clin Chim Acta; 2010 Jan 30; 411(1-2):77-80. PubMed ID: 19835852
    [Abstract] [Full Text] [Related]

  • 20. Heterophilic antibody interference in a non-endogenous molecule assay: an apparent elevation in the tacrolimus concentration.
    Altinier S, Varagnolo M, Zaninotto M, Boccagni P, Plebani M.
    Clin Chim Acta; 2009 Apr 30; 402(1-2):193-5. PubMed ID: 19150346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.